Table 2 APOE e2/e4 logistic regressions for AD neuropathologies.

From: Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies

Variable

Contrast

OR

CI

Chi-square

p

APOE e2/e4 contrasts and neuritic plaque

NEUR

e24 v e2

4.91

2.43–9.73

24.80

<0.0001

NEUR

e24 v e3

2.85

1.56–5.20

13.91

0.0006

NEUR

e24 v e4

1.07

0.58–1.97

0.10

0.84

APOE e2/e4 contrasts and Braak stage

BRAAK

e2/e4 v e2

5.64

2.92–10.90

30.00

<0.0001

BRAAK

e2/e4 v e3

2.83

1.62–4.99

15.57

0.0003

BRAAK

e2/e4 v e4

1.11

0.63–1.95

0.14

0.72

APOE e2/e4 and Thal diffuse plaque

THAL

e24 v e2

5.53

2.86–10.73

27.93

<0.0001

THAL

e24 v e3

2.41

1.37–4.25

10.84

0.001

THAL

e24 v e4

1.12

0.60–1.98

0.19

0.66

Back to article page